Underutilization of Combined-Modality Therapy in Limited-Stage Small Cell Lung Cancer-Reply

JAMA Oncol. 2018 Oct 1;4(10):1436-1437. doi: 10.1001/jamaoncol.2018.3292.

Authors

Stephen G Chun¹, Todd A Pezzi¹, David L Schwartz^{1

2}

Affiliations

¹ Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston.
² Department of Radiation Oncology, University of Tennessee Health Science Center, Memphis.

PMID: 30073269
DOI: 10.1001/jamaoncol.2018.3292

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Non-Small-Cell Lung*
Combined Modality Therapy
Humans
Lung Neoplasms*
Small Cell Lung Carcinoma*